CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland
Summary
GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Poland. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Poland. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The Poland healthcare market is one of the major emerging markets in Central Europe, with a strong focus on healthcare reforms and R&D. The pharmaceutical market of Poland increased from €6.34B in 2011 to €7.54B in 2017 at a Compound Annual Growth Rate (CAGR) of 2.92%. However, in terms of USD, the pharmaceutical market decreased from $8.82B in 2011 to $8.52B in 2017, at a negative CAGR of 0.57%. The Poland medical devices market was valued at $2.79B in 2015, which increased at a CAGR of 4% to reach $3.27B in 2019.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Poland, and includes -
- An overview of the pharmaceutical markets, comprising market size, segmentation, COVID-19 epidemiology and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, GSK, Sanofi, Teva and PolPharma)
- Profiles and SWOT analyses of the major players in the medical device market (Abbott, Medtronic, GE Healthcare, Stryker, and Mercator Medical)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Poland
- Information regarding the health-tech landscape of the country along with the major health-tech deals
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Polish healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Polish healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analysing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Polish healthcare market
Summary:
Get latest Market Research Reports on CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland. Industry analysis & Market Report on CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland is a syndicated market report, published as CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland. It is complete Research Study and Industry Analysis of CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.